ASX - By Stock
|
PAA |
Re:
PAA Chart
|
|
Cashtrain
|
269 |
66K |
8 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
269
|
66K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Extension Study Begins, Analysis Suggests Survival Benefit
|
|
Cashtrain
|
197 |
48K |
21 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
197
|
48K
|
21
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust to present at NWR Virtual Healthcare Conference
|
|
Cashtrain
|
126 |
28K |
2 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
126
|
28K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust to present at NWR Virtual Healthcare Conference
|
|
Cashtrain
|
126 |
28K |
16 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
126
|
28K
|
16
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Great Pharmaust FDA ODD Approval Sweepstake
|
|
Cashtrain
|
175 |
27K |
8 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
175
|
27K
|
8
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Great Pharmaust FDA ODD Approval Sweepstake
|
|
Cashtrain
|
175 |
27K |
15 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
175
|
27K
|
15
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Great Pharmaust FDA ODD Approval Sweepstake
|
|
Cashtrain
|
175 |
27K |
7 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
175
|
27K
|
7
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Great Pharmaust FDA ODD Approval Sweepstake
|
|
Cashtrain
|
175 |
27K |
5 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
175
|
27K
|
5
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Great Pharmaust FDA ODD Approval Sweepstake
|
|
Cashtrain
|
175 |
27K |
8 |
18/03/24 |
18/03/24 |
ASX - By Stock
|
175
|
27K
|
8
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Great Pharmaust FDA ODD Approval Sweepstake
|
|
Cashtrain
|
175 |
27K |
8 |
18/03/24 |
18/03/24 |
ASX - By Stock
|
175
|
27K
|
8
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Great Pharmaust FDA ODD Approval Sweepstake
|
|
Cashtrain
|
175 |
27K |
7 |
18/03/24 |
18/03/24 |
ASX - By Stock
|
175
|
27K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
Cashtrain
|
304 |
71K |
8 |
17/03/24 |
17/03/24 |
ASX - By Stock
|
304
|
71K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Singapore Healthcare Day Presentation
|
|
Cashtrain
|
63 |
15K |
14 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
63
|
15K
|
14
|
|
ASX - By Stock
|
PAA |
Re:
Big Pharma buyouts.
|
|
Cashtrain
|
39 |
8.6K |
7 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
39
|
8.6K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
PAA Chart
|
|
Cashtrain
|
269 |
66K |
5 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
269
|
66K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Big Pharma buyouts.
|
|
Cashtrain
|
39 |
8.6K |
9 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
39
|
8.6K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Amylyx class action Relyvrio
|
|
Cashtrain
|
58 |
14K |
17 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
58
|
14K
|
17
|
|
ASX - By Stock
|
PAA |
Re:
Amylyx class action Relyvrio
|
|
Cashtrain
|
58 |
14K |
15 |
09/03/24 |
09/03/24 |
ASX - By Stock
|
58
|
14K
|
15
|
|
ASX - By Stock
|
PAA |
Re:
Amylyx class action Relyvrio
|
|
Cashtrain
|
58 |
14K |
10 |
09/03/24 |
09/03/24 |
ASX - By Stock
|
58
|
14K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Amylyx class action Relyvrio
|
|
Cashtrain
|
58 |
14K |
21 |
09/03/24 |
09/03/24 |
ASX - By Stock
|
58
|
14K
|
21
|
|
ASX - By Stock
|
PAA |
Re:
Amylyx class action Relyvrio
|
|
Cashtrain
|
58 |
14K |
10 |
09/03/24 |
09/03/24 |
ASX - By Stock
|
58
|
14K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Application for quotation of securities - PAA
|
|
Cashtrain
|
77 |
17K |
8 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
77
|
17K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
Cashtrain
|
304 |
71K |
10 |
05/03/24 |
05/03/24 |
ASX - By Stock
|
304
|
71K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
Cashtrain
|
304 |
71K |
13 |
04/03/24 |
04/03/24 |
ASX - By Stock
|
304
|
71K
|
13
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
Cashtrain
|
304 |
71K |
3 |
04/03/24 |
04/03/24 |
ASX - By Stock
|
304
|
71K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
Cashtrain
|
304 |
71K |
6 |
03/03/24 |
03/03/24 |
ASX - By Stock
|
304
|
71K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
Cashtrain
|
304 |
71K |
5 |
02/03/24 |
02/03/24 |
ASX - By Stock
|
304
|
71K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
Cashtrain
|
304 |
71K |
11 |
02/03/24 |
02/03/24 |
ASX - By Stock
|
304
|
71K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
Cashtrain
|
304 |
71K |
18 |
02/03/24 |
02/03/24 |
ASX - By Stock
|
304
|
71K
|
18
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Cashtrain
|
971 |
226K |
10 |
02/03/24 |
02/03/24 |
ASX - By Stock
|
971
|
226K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
Cashtrain
|
304 |
71K |
7 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
304
|
71K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
Cashtrain
|
304 |
71K |
4 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
304
|
71K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
Cashtrain
|
304 |
71K |
3 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
304
|
71K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
Cashtrain
|
304 |
71K |
15 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
304
|
71K
|
15
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
Cashtrain
|
304 |
71K |
14 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
304
|
71K
|
14
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
Cashtrain
|
304 |
71K |
3 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
304
|
71K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
Cashtrain
|
304 |
71K |
12 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
304
|
71K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
Cashtrain
|
304 |
71K |
2 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
304
|
71K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
Cashtrain
|
304 |
71K |
2 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
304
|
71K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
X
|
|
Cashtrain
|
9 |
2.2K |
2 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
9
|
2.2K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust media thread
|
|
Cashtrain
|
304 |
71K |
7 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
304
|
71K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Positive Phase 1 MEND Study Top-Line Results
|
|
Cashtrain
|
152 |
42K |
6 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
152
|
42K
|
6
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Cashtrain
|
971 |
226K |
2 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
971
|
226K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Sparks Valuation Pharmaust
|
|
Cashtrain
|
111 |
33K |
4 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
111
|
33K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Sparks Valuation Pharmaust
|
|
Cashtrain
|
111 |
33K |
8 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
111
|
33K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Positive Phase 1 MEND Study Top-Line Results
|
|
Cashtrain
|
152 |
42K |
3 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
152
|
42K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Positive Phase 1 MEND Study Top-Line Results
|
|
Cashtrain
|
152 |
42K |
5 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
152
|
42K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Positive Phase 1 MEND Study Top-Line Results
|
|
Cashtrain
|
152 |
42K |
13 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
152
|
42K
|
13
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Positive Phase 1 MEND Study Top-Line Results
|
|
Cashtrain
|
152 |
42K |
12 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
152
|
42K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Positive Phase 1 MEND Study Top-Line Results
|
|
Cashtrain
|
152 |
42K |
10 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
152
|
42K
|
10
|
|